Stay updated on Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial page.

Latest updates to the Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial page
- Check3 days agoChange DetectedAdded a Locations section with Kangnam as a recruitment site. The previous Kangnam Locations entry is removed and the page revision is updated to v3.3.3.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe Publications note was updated to say items are automatically filled from PubMed, and a new revision tag v3.3.2 was added (replacing v3.2.0).SummaryDifference0.1%

- Check38 days agoChange DetectedRemoved the government funding lapse notice about operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedThe changes are limited to layout and formatting adjustments; core study details such as inclusion criteria, pembrolizumab treatment, and outcome measures remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference3%

- Check88 days agoChange DetectedPage now shows version upgrade to v3.1.0 and adds two new contact-like numbers (82-10-9933-3483 and 82-2-3410-6763), replacing the old version tag v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial page.